Zalicus

Industry · 12 registered clinical trials.

Status	Trial	Phase	Started
Completed	Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia Postherpetic Neuralgia	Phase 2	2012-12-01
Completed	Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy Lumbosacral Radiculopathy	Phase 2	2012-08-01
Terminated	Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis Rheumatoid Arthritis	Phase 2	2012-03-01
Completed	A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis Rheumatoid Arthritis	Phase 2	2011-06-01
Completed	A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis Plaque Psoriasis	Phase 2	2008-11-01
Completed	A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers Atopic Dermatitis	Phase 1	2008-07-01
Completed	Study of CRx-191 to Assess Activity in Plaque Psoriasis Plaque Psoriasis	Phase 2	2007-11-01
Completed	Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis Rheumatoid Arthritis	Phase 2	2007-10-01
Completed	Phase I Study of Topical CRx-191 in Normal Healthy Volunteers Healthy	Phase 1	2007-09-01
Terminated	CRx-102 Osteoarthritis Multicenter Evaluation Trial Knee Osteoarthritis	Phase 2	2007-08-01
Completed	Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes Type 2 Diabetes	Phase 2	2007-07-01
Completed	A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD The Rheumatoid Arthritis	Phase 2	2004-11-01